FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIU, Y.
Right arrow Articles by SENGER, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIU, Y.
Right arrow Articles by SENGER, D. R.
(The FASEB Journal. 2004;18:457-468.)
© 2004 FASEB

Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells

YANQIU LIU and DONALD R. SENGER1

Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA

1Correspondence: Department of Pathology, Research North, Beth Israel Deaconess Medical Center, 99 Brookline Ave., Boston, MA 02215, USA. E-mail: dsenger{at}caregroup.harvard.edu


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Interstitial collagen I stimulates microvascular endothelial cells to form solid cords that imitate precapillary structures found during angiogenesis. Time-lapse microscopy identified cell retraction and disruption of cell–cell contacts as early critical steps in collagen I-induced capillary morphogenesis. These early stages paralleled collagen I activation of Src kinase and GTPase Rho through ß1 integrins. The Src inhibitor PP2, dominant-negative Src, and Rho inhibitor exoenzyme C3 transferase each inhibited collagen I induction of actin stress fibers that mediate cell retraction and each inhibited capillary morphogenesis. Collagen I also disrupted VE-cadherin from intercellular junctions through a Src-dependent mechanism; both the Src inhibitor PP2 and dominant-negative Src preserved VE-cadherin localization to regions of cell–cell contact. An active Src mutant disrupted VE-cadherin and cell–cell contacts similarly to collagen I. In sharp contrast, laminin-1 did not induce capillary morphogenesis, and laminin-1 did not induce activation of Src or Rho. Rather, laminin-1 induced persistent activation of the GTPase Rac. Thus, these studies identify activation of Src and Rho as key mechanisms by which collagen I provokes capillary morphogenesis of microvascular endothelial cells, and they define marked differences between the functions of collagen I and laminin-1 in regulating endothelial cell morphogenesis.—Liu, Y., Senger, D. R. Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells.


Key Words: angiogenesis • collagen • laminin • ß1 integrins • VE-cadherin


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
THE ENDOTHELIAL CELLS (ECs) of mature blood vessels normally are sequestered from interstitial collagens by a continuous basal lamina consisting predominantly of laminins and type IV collagen. However, during the sprouting phase of angiogenesis, proliferating ECs degrade the underlying basal lamina and migrate within connective tissue rich in interstitial collagens (1 , 2) . The process whereby sprouting ECs reorganize into new capillary networks within the interstitial matrix has been studied most extensively in the embryo, where capillary development starts with transition of endothelial precursor cells to a spindle-shaped morphology (3) . Coincident with this spindle-shaped transition, EC precursors align into solid, precapillary cord-like structures (4 , 5) that are interconnected to form a polygonal network (3 , 6) . Solid precapillary cords also form during angiogenesis in the adult (7) . During maturation, solid vascular cords form hollow lumens for the transport of blood (3 , 7) and ECs are again sequestered from the interstitial matrix through establishment of a continuous basal lamina.

Interestingly, interstitial collagen I provokes ECs in vitro to initiate a morphogenetic program that imitates the early stages of capillary formation in vivo. After addition of collagen I to monolayer cultures, ECs retract and realign to form solid precapillary cords organized in a polygonal pattern (8 9 10 11 12) . Furthermore, expression of collagen I by isolated EC clones closely correlates with spontaneous capillary morphogenesis (13 , 14) . In ECs isolated from the microvasculature, collagen I-induced capillary morphogenesis is mediated by the {alpha}1ß1 and {alpha}2ß1 integrins (15) and expression of these integrins is selectively induced by the angiogenic cytokine VEGF (16) . Moreover, antagonism of the {alpha}1ß1 and {alpha}2ß1 integrins inhibits angiogenesis in vivo (16 , 17) .

In contrast to ECs, fibroblasts, which also express integrins {alpha}1ß1 and {alpha}2ß1, do not respond to collagen I with increased actin polymerization, changes in cell shape, or cellular alignment into cords (15) ; this may relate to the fact that fibroblasts normally reside within interstitial collagens. On the other hand, ECs encounter collagen I only during the sprouting and invasive stages of angiogenesis. Thus, collagen I is appropriately situated to serve as a stimulus for EC reorganization. The findings summarized above indicating that collagen I drives capillary morphogenesis clearly suggest the hypothesis that collagen I is an activator of EC signal transduction pathways that regulate EC morphogenesis. However, at the molecular level, the underlying mechanisms by which collagen I stimulates ECs to regulate cell shape and multicellular organization have largely been unexplored. Additionally, the possibility that basement membrane laminins on which quiescent ECs normally reside and interstitial collagens in which sprouting angiogenesis and cord formation occurs provoke distinctly different signaling in ECs has not been examined. Therefore, we designed experiments to address these questions with isolated human dermal microvascular ECs in culture.

Because it seemed probable that dynamic changes in cytoskeletal organization are pivotal for EC morphogenesis, we hypothesized that collagen I controls the activities of signaling molecules that regulate the actin cytoskeleton, and we tested the involvement of Src kinases and Rho GTPases. Src kinases are known to regulate the cytoskeleton and cellular processes relevant to vascular morphogenesis including cell adhesion and motility (18) . Src kinases have been implicated in angiogenesis, especially in regulating vascular permeability (19) ; however, the function of Src kinases in regulating morphogenesis of vascular ECs has not been explored. Rho GTPases are also critical for regulating cytoskeletal organization, and Rho family members have been implicated in cell movement and morphogenetic processes involving changes in cell shape and polarity (20 , 21) .

Experiments described here confirmed the hypothesis that collagen I activates key regulators of the actin cytoskeleton in microvascular ECs and identified activation of both Src and Rho as previously unrecognized, critical mechanisms by which collagen I ligation of ß1 integrins drives microvascular EC reorganization into precapillary cords. In sharp contrast to collagen I, basement laminin-1 does not activate Src or Rho, consistent with findings that laminin-1 does not provoke cord formation. Thus, these experiments identified key signaling molecules by which collagen I drives morphogenesis of microvascular ECs and defined major differences between signaling provoked by collagen I and basement membrane laminin-1.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Cells, culture conditions, retroviral constructs, and retroviral transduction
Human dermal microvascular ECs were isolated from neonatal foreskins and cultured as described (11) . Cells were used at the fourth to seventh passage.

Dominant negative Src (dn-Src) (K295R/Y527F) (22) , dominant active Src (da-Src)(Y527F), and wild-type Src (wt-Src) in the pLNCX retroviral vector were kindly provided by Dr. Joan Brugge (Department of Cell Biology, Harvard Medical School, Boston, MA, USA). Retrovirus was prepared by transfecting PT67 retroviral packaging cells (Clontech, Palo Alto, CA, USA) and stable transfected clones expressing 1 x 105 c.f.u./mL were selected as a source of retrovirus. For retroviral transduction, microvascular ECs at passage 4 were grown to 30% confluence on a 10 cm dish and transduced separately with retroviruses encoding dn-Src, da-Src, wt-Src, and green fluorescent protein (GFP) (23) . VEGF (20 ng/mL) was added to enhance proliferation and survival during the transduction procedure, which was repeated three times on consecutive days before subjecting cells to selection with 200 µg/mL G418. This procedure provided >90% transduction as monitored by fluorescence associated with cells transduced with GFP control retrovirus.

Stimulation of microvascular ECs with collagen I and laminin-1: incubation with Src and Rho inhibitors and ß1 integrin-blocking antibody
Replicate wells or flasks of microvascular ECs were grown to confluence in standard medium (see above). Twenty-four hours before stimulation with matrix proteins, the culture medium was removed and replaced with basal medium (EBM-2, Clonetics, San Diego, CA, USA) containing 2% fetal bovine serum. Acid-solubilized rat tail collagen I (BD Biosciences, Bedford, MA, USA) was neutralized according to the manufacturer’s instructions and diluted in serum-free EBM-2 medium to a concentration of 250 µg/mL unless indicated otherwise. Mouse laminin-1 (BD Biosciences) was diluted in serum-free EBM-2 to the same concentration as collagen I. For experiments, culture medium was gently removed from the cells and replaced with the collagen I-containing or laminin-1-containing serum-free medium. Where indicated, the following inhibitors were added: PP2 (Calbiochem, San Diego, CA, USA), a potent and selective inhibitor of the Src kinase family of protein tyrosine kinases, and recombinant exoenzyme C3 transferase (Cytoskeleton, Denver, CO, USA), a potent and selective inhibitor of Rho. For experiments with PP2, cells were preincubated with drug 30 min before the experiment. For C3, which is not as cell permeable, cells were preincubated overnight. For experiments with ß1 integrin-blocking monoclonal antibody (clone P4C10; Gibco, Carlsbad, CA, USA), cells were preincubated with purified antibody (20 µg/mL) for 30 min and antibody was included throughout the experimental interval. A matched purified isotype monoclonal antibody (MOPC 21; Sigma, St. Louis, MO, USA) served as control.

Phase and time-lapse phase photomicroscopy
Standard phase contrast images were collected with a Leica DC200 digital camera and associated software. For time-lapse experiments, microvascular ECs were cultured to confluence in a 25 cm2 flask. Two hours before stimulation with collagen I or laminin-1, the cell medium was changed to EBM-2 medium containing 2% fetal bovine serum. Subsequently, serum-free medium containing collagen I, collagen I with inhibitors, or laminin-1 was added to the cells; the flask was purged with 5% CO2, then sealed tightly. The cells were visualized using a phase-contrast inverted microscope (model Diaphot 300; Nikon, Inc., Melville, NY, USA) equipped with a stage heated to 37°C and images were recorded at 10 min intervals using a CCD (charge-coupled device) camera (Dage-MTI, Michigan City, IN, USA), a frame grabber (Scion, Frederick, MD, USA), IP LAB software (Scanalytics; Billerica, MA, USA), and a Macintosh computer.

Immuno-fluorescence microscopy
For F-actin staining, cells seeded on glass coverslips were fixed for 30 min in 3.7% buffered formaldehyde, then washed with phosphate-buffered saline (PBS). The cells were stained for F-actin with a solution of 1% BSA in PBS containing 0.1% Triton X-100 and Texas Red-labeled phalloidin (1:40 dilution; Molecular Probes, Eugene, OR, USA) for 45 min. Coverslips were washed three times with PBS and mounted with Vectashield mounting medium with DAPI (Vector Laboratories, Burlingame, CA, USA). For VE-cadherin staining, cells on coverslips were fixed for 10 min in acetone:methanol (1:1) at -20°C, air dried, and incubated with goat antibody against VE-cadherin (SC-6458; Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 1:200 for 1 h. After three washes with PBS, coverslips were incubated with fluorescein-conjugated donkey anti-goat IgG (Santa Cruz) at 1:200 for 45 min and washed again three times with PBS. Finally, coverslips were mounted and sealed for observation. Fluorescence images were collected with a Leica DC200 digital camera and associated software.

Western blot
Cell lysates were prepared by adding ice-cold lysis buffer (20 mM Tris-HCL, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM CaCl2, 1 mM MgCl2, 10% glycerol, protease inhibitor cocktail (#P8340, Sigma), 1 mM EDTA, and 1 mM EGTA) to cells and shaking for 30 min at 4°C. Cells were scraped and centrifuged for 10 min (14,000 rpm) at 4°C. Protein concentrations of the supernatants were determined by DC Protein Assay kit (BioRad, Richmond, CA, USA). Equal amounts of protein were loaded for electrophoresis on 4–12% tris-glycine sodium dodecyl sulfate (SDS) polyacrylamide gradient gels (Invitrogen, Carlsbad, CA, USA), then transferred to PVDF membranes (Millipore Corp., Bedford, MA, USA). The membrane was incubated with 0.5 µg/mL rabbit anti-Src [PY418] phospho-specific antibody (Biosource International, Camarillo, CA, USA) in Tris-buffered saline containing 3% BSA and 0.1% (v/v) Tween-20 for 1 h. The membrane was washed three times in Tris-buffered saline containing 0.1% (v/v) Tween-20, followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody for 1 h. Immunoreactive bands were detected by enhanced chemiluminescence (Renaissance from NEN, Boston, MA, USA).

Assays for Rho and Rac activity
Active GTP-Rho was measured with an established method (24) involving affinity precipitation of cell lysates with glutathione-Sepharose beads coated with a glutathione S-transferase fusion protein containing the GTP-Rho binding domain of Rhotekin. Bound active Rho and total cell lysates were separately subjected to SDS polyacrylamide electrophoresis (25) , transferred to PVDF membrane, and stained with rabbit polyclonal antibody to RhoA (#SC-179, Santa Cruz Biotechnology), followed by staining with secondary antibody and visualization of the stained bands with chemiluminescence as described above. Rac activity was measured by affinity precipitation of GTP-Rac with PAK-agarose beads (Rac activation assay kit, Upstate Biotechnology, Lake Placid, NY, USA) according to the manufacturer’s instructions. Bound active Rac and total cell lysates were subjected to electrophoresis and blotting as described above. Rac was detected by staining with mouse anti-Rac antibody (Upstate Biotechnology).


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Collagen I, not laminin-1, initiates capillary morphogenesis, and morphogenesis coincides with activation of Src and Rho
There are multiple strategies for studying collagen signaling in microvascular ECs, including approaches that begin with cells in suspension. However, during the sprouting phase of angiogenesis, adherent ECs proliferate and reorganize in a 3-dimensional, collagen-rich matrix. Therefore, we studied the consequences of adding 3-dimensional interstitial collagen I to adherent microvascular ECs because this experimental approach better imitates the circumstances of ECs at the sprouting tips of blood vessels.

As illustrated in Fig. 1 A, adherent dermal microvascular ECs responded to addition of collagen I by retracting and realigning into polygonal arrays of cord-like structures within 5 h. This morphogenetic process closely imitates an early organizational step in the formation of vascular plexuses during embryonic development in vivo (3 , 6) ; as we showed earlier, the marked shape changes induced by collagen I are not due to induction of apoptosis or cell death (15) . In sharp contrast to collagen I, equivalent concentrations of laminin-1 had no significant effects on cell shape (Fig. 1A ).



View larger version (63K):
[in this window]
[in a new window]
 
Figure 1. Collagen I, not laminin-1, initiates capillary morphogenesis, and collagen I-induced morphogenesis coincides with activation of Src and Rho. A) Control: control microvascular ECs grown to confluence; Collagen I: confluent microvascular ECs to which collagen I (250 µg/mL) had been added 5 h before; laminin-1: confluent microvascular ECs to which laminin-1 (250 µg/mL) had been added 5 h earlier. B) Upper panel: immunoblot stained with phospho-tyrosine antibody (PY20) demonstrating that, compared with laminin-1, collagen I induces strong tyrosine phosphorylation in microvascular ECs and especially phosphorylation of a prominent band corresponding to 85 kDa. Immunoprecipitation identified this band as cortactin, a substrate for Src (not shown). Lower panel: with similar kinetics, collagen I, but not laminin-1, induces activation of Src as determined with phospho-specific antibody to Src tyrosine residue 418. C) Rho activity assay demonstrating that stimulation of microvascular ECs with collagen I activates Rho, whereas stimulation with laminin-1 results in gradual loss of Rho activity. D) Rac activity assay demonstrating that collagen I provokes a transient and short-lived activation of Rac that is followed by a marked decline to less than control levels. In contrast, laminin-1 provokes a gradual and persistent activation of Rac.

To identify differences in signaling associated with collagen I vs. laminin-1 stimulation, we began by investigating tyrosine phosphorylation in cells stimulated by these two matrices. Collagen I strongly induced tyrosine phosphorylation in microvascular ECs compared with laminin-1 (Fig. 1B , upper panel). Within 1 h collagen I strongly induced tyrosine phosphorylation of a band corresponding to ~85 kDa; this band was absent or undetectable in cells stimulated with laminin-1. Immunoprecipitation analyses identified this prominent tyrosine phosphorylated band as cortactin (not shown). Since cortactin is a prominent substrate for tyrosine phosphorylation by Src (26) , we next investigated the possibility that collagen I induces Src activation in microvascular ECs. As shown in Fig. 1B (lower panel), collagen I but not laminin-1 induced phosphorylation of Src on tyrosine residue 418 by 1 h, with a substantial further increase by 3 h. Phosphorylation of this residue is indicative of Src kinase activation (27 , 28) ; thus, these experiments indicate that collagen I induces a sustained activation of Src in microvascular ECs and that this activity is not shared by laminin-1.

The morphological changes induced by collagen I in microvascular ECs involves rearrangement of actin cytoskeleton (15) , and so we considered the possibility that collagen I regulates the activities of Rho family GTPases which are critically involved in cytoskeletal regulation (20 , 21) . With Rho activity assays, we established that Rho was markedly activated by collagen I with detectable increases by 30 min and a sustained increase through 3 h (Fig. 1C ). In marked contrast, stimulation of microvascular ECs by laminin-1 suppressed Rho activity (Fig. 1C ). Moreover, as determined with Rac activity assays, collagen I provoked a rapid and transient increase in Rac activity; this was followed by a marked decline: by 3 h Rac activity was less than before collagen I stimulation. In contrast, laminin-1 provoked a gradual but sustained increase in Rac activity (Fig. 1D ). These experiments established that stimulation of microvascular ECs with collagen I provokes a sustained increase in Rho activity, but laminin-1 provokes a decline in Rho activity. Moreover, laminin-1 provokes a sustained activation of Rac whereas collagen I provokes a transient increase in Rac activity, followed by a decline to sub-baseline levels. Thus, Rho and Rac are regulated differently by collagen I and laminin-1 in microvascular ECs.

Inhibition of Src and Rho suppresses capillary morphogenesis induced by collagen I
Because collagen I stimulation of microvascular ECs provokes a sustained activation of Src and Rho whereas laminin-1 does not, we investigated the importance of Src and Rho activities for collagen I-induced morphogenesis and formation of precapillary cords. We used time-lapse phase microscopy to determine whether inhibitors of Src and Rho, individually and in combination, block collagen I-induced morphogenesis. As shown in Fig. 2 A, collagen I induced disruption of the monolayer within 2 h, and cell reorganization into cords continued during the ensuing 3 h. In contrast, laminin-1 did not provoke significant shape changes during this interval. Videos constructed with images collected at 10 min intervals indicated that collagen I-induced reorganization of microvascular ECs into cords involves not only cell retraction but also motility and cell realignment. As shown in Fig. 2A , the Src family kinase inhibitor PP2 and the Rho inhibitor C3 transferase both suppressed the morphological changes provoked by collagen I. Most significantly, the combination of PP2 and C3 abolished collagen I-induced cord formation (Fig. 2A ). Furthermore, as shown in Fig. 2B (high-power views of the panels shown in Fig. 2A ), both PP2 and C3 blocked cell retraction, which is critical to the process of cord formation. Thus, these experiments implicate Src and Rho activity as critical for the mechanism by which collagen I induces EC morphogenesis and formation of precapillary cords.



View larger version (90K):
[in this window]
[in a new window]
 
Figure 2. Inhibition of Src and Rho blocks collagen I-induced morphogenesis of microvascular ECs. A) Time-lapse phase-contrast microscopy indicated that collagen I-induced morphogenesis and cord formation is evident by 2 h and progresses during the next 3 h. In contrast, laminin-1 does not induce significant changes in cell shape. Collagen I-induced cord formation is inhibited separately by the Src inhibitor PP2 (1 µM) and the Rho inhibitor C3 transferase (10 µg/mL); in combination, PP2 and C3 completely suppress cord formation. B. Higher power views of frames shown in panel A showed that PP2 and C3 each inhibited cell retraction, which is required for cord formation.

To further test the function of Src in capillary morphogenesis, we transduced microvascular ECs with the retroviruses encoding wild-type Src (wt-Src) and a dominant-negative Src mutant (dn-Src). Transduction with either wt-Src or dn-Src did not affect cell morphology significantly in the absence of collagen I. However, as shown in Fig. 3 , human dermal microvascular ECs transduced with dn-Src failed to form typical cord-like structures in response to collagen I stimulation, consistent with experiments involving the Src inhibitor PP2 (Fig. 2) . Furthermore, dermal microvascular ECs transduced with wt-Src formed cords more rapidly than cells transduced with control retrovirus encoding GFP. Thus, these experiments using retroviral transduction independently establish the importance of Src for collagen I-induced reorganization of microvascular ECs into precapillary cords.



View larger version (63K):
[in this window]
[in a new window]
 
Figure 3. Transduction with dn-Src and wt-Src alters collagen I-induced morphogenesis. Similar to the Src inhibitor PP2, expression of dn-Src in human dermal microvascular ECs suppressed the morphological changes induced by collagen I. Collagen I provoked microvascular ECs transduced with wt-Src to form cords more quickly than cells transduced with control retrovirus. Cells were stimulated in parallel with collagen I for 3 h.

Inhibition of Src and Rho suppresses collagen I induction of actin stress fibers in microvascular ECs
Time-lapse images presented in Fig. 2B indicated that collagen I-induced capillary morphogenesis involves cell retraction and that retraction is inhibited by blocking either Src or Rho. These findings suggested the possibility that Src and Rho mediate important cytoskeletal changes in response to collagen I. Therefore, we investigated the functions of Src and Rho in regulating actin stress fibers induced by collagen I that are required for the formation of precapillary cords (15) . As shown in Fig. 4 A, collagen I induced prominent actin stress fibers traversing the body of the cell; Src inhibitor PP2 and the Rho inhibitor C3 both substantially reduced collagen I-induced stress fiber formation. As reported by us earlier, laminin-1 did not induce stress fibers in these experiments (15) ; as shown in Fig. 1 , laminin-1 did not activate Src or Rho. Thus, these experiments implicate both Src and Rho as important to the mechanism by which collagen I selectively induces actin stress fibers in microvascular ECs. Because the formation of stress fibers is critical for the formation of precapillary cords (15) , these experiments define a specific contribution of Src and Rho to the mechanism by which collagen I initiates capillary morphogenesis.



View larger version (45K):
[in this window]
[in a new window]
 
Figure 4. Inhibition of Src and Rho inhibits collagen I induction of actin stress fibers, and inhibition of Src prevents collagen I disruption of VE-cadherin in microvascular ECs. A) As indicated by staining with Texas Red-phalloidin, collagen I induced prominent actin stress fibers (right top panel, time=5 h). As shown in lower panels, the Src inhibitor PP2 (1 µM) and the Rho inhibitor C3 (10 µg/mL) each markedly suppressed collagen I induction of stress fibers. B) Continuous VE-cadherin staining, which is normally observed in microvascular ECs at cell–cell junctions, was disrupted by collagen I but not by laminin-1 (time=3 h). The Src inhibitor PP2 (1 µM) prevented collagen I-mediated disruption of VE-cadherin from cell–cell junctions, whereas the Rho inhibitor C3 (10 µg/mL) was less effective and did not preserve continuous VE-cadherin staining.

Activation of Src by collagen I disrupts VE-cadherin from cell–cell contacts
The videos constructed from time-lapse microscopy (see Fig. 2 for sample images) also indicated that collagen I initiated the formation of precapillary cords by provoking the appearance of evenly distributed gaps between cells in the monolayer. The Src inhibitor PP2 suppressed the early formation of gaps; experiments with the Rho inhibitor C3 also suggested inhibition, although C3 was less effective than PP2. Thus, these findings suggested that collagen I activation of Src mediates disruption of cell–cell contacts, thereby facilitating motility, cell retraction, and the realignment of microvascular ECs into precapillary cords.

Because VE-cadherin localization to regions of cell–cell contact is indicative of the integrity of EC junctions (29) , we investigated the consequences of collagen I stimulation for VE-cadherin. As shown in Fig. 4B , typical VE-cadherin staining indicative of intact cell–cell junctions was observed continuously along regions of cell–cell contacts in control cells grown to confluence. Stimulation with laminin-1 was without effect, but VE-cadherin staining was markedly reduced in cells stimulated with collagen I. The Src inhibitor PP2 effectively preserved VE-cadherin staining after collagen I stimulation whereas the Rho inhibitor C3 was less effective. These findings suggest an important role for Src activation in the mechanism whereby collagen I stimulation provokes disruption of VE-cadherin localization and cell–cell contacts, and are consistent with our findings that collagen I, not laminin-1, activates Src.

Transduction of microvascular ECs with retroviruses encoding Src mutants establishes a critical function for Src in mediating both collagen I induction of actin stress fibers and collagen I disruption of VE-cadherin
It is well established that Rho activation induces the formation of actin stress fibers (20 , 21 , 30 , 31) , so our findings that collagen I induces Rho activation, actin stress fibers, and retraction of microvascular ECs (Figs. 1 , 2 , 4) are consistent with the known function of Rho. However, a role for Src activation in the formation of actin stress fibers was less expected. To further test our findings presented in Fig. 4A with the Src inhibitor PP2, we used microvascular ECs transduced with dn-Src and wt-Src. In the absence of stimulation by collagen I, cells transduced with dn-Src or wt-Src contained actin stress fibers similar to cells transduced with control vector encoding GFP (not shown). However, in the presence of collagen I stimulation, expression of dn-Src markedly reduced formation of actin stress fibers compared with control (Fig. 5 A). Transduction of cells with wt-Src resulted in increased formation of actin stress fibers in response to collagen I stimulation. Thus, our findings with cells transduced by dn-Src or wt-Src (Fig. 5A ) and experiments involving the Src inhibitor PP2 (Fig. 4A ) are consistent: they establish that activation of Src is critical to the mechanism by which collagen I induces actin stress fibers in microvascular ECs.



View larger version (57K):
[in this window]
[in a new window]
 
Figure 5. Transduction of microvascular ECs with Src mutants and consequences for collagen I induction of actin stress fibers and collagen I disruption of VE-cadherin. A) Microvascular ECs transduced with dn-Src responded to stimulation by collagen I with reduced formation of stress fibers compared with cells transduced with control retrovirus. Compared with control, stress fiber formation in response to collagen I was enhanced in cells transduced with wt-Src. B) Transduction of microvascular ECs with dn-Src inhibited collagen I-mediated disruption of VE-cadherin from cell–cell junctions and cell borders (time=3 h). In contrast, transduction with wt-Src enhanced collagen I-mediated disruption of VE-cadherin staining compared with control. C) In the absence of collagen I, typically continuous VE-cadherin staining was observed at cell–cell junctions of cells transduced either with control (GFP), wt-Src, or dn-Src retrovirus. However, in sharp contrast, cells transduced with da-Src failed to form junctions with continuous localization of VE-cadherin.

To test our findings with the Src inhibitor PP2 implicating Src activation as important to the mechanism by which collagen I disrupts VE-cadherin, we transduced microvascular ECs with retroviruses encoding dn-Src and wt-Src. In the absence of collagen I, confluent cells transduced with dn-Src, wt-Src, and control retrovirus encoding GFP revealed normal patterns of VE-cadherin distribution identical to untransduced cells, as shown in Fig. 5C . However, marked differences among these cell populations were observed after stimulation with collagen I. As shown in Fig. 5B , transduction with dn-Src preserved VE-cadherin staining at cell borders of collagen I-stimulated cells, similar to effects of the Src inhibitor PP2 (Fig. 4B ). In contrast, collagen I stimulation of cells transduced with wt-Src resulted in more extensive disruption of VE-cadherin localization compared with control. We also observed that in the absence of collagen I, cells transduced with a dominant active Src mutant (da-Src) exhibited marked reduction in VE-cadherin staining from cell borders (Fig. 5C ). Thus, these experiments all indicate that Src activity regulates the localization of VE-cadherin in microvascular ECs and they establish that collagen I activation of Src is important for the mechanism by which collagen I disrupts VE-cadherin localization and cell–cell contacts.

Collagen I activates Src and Rho in microvascular ECs through ligation of ß1 integrins
We had shown that collagen I stimulation of microvascular ECs to form precapillary cords involves binding of ß1 integrins by collagen I (15) . To determine whether binding of ß1 integrins by collagen I is also critical to the mechanism by which collagen I activates Src and Rho in these cells, we used monoclonal antibody P4C10, which blocks collagen I binding to ß1 integrins. This antibody inhibited Src activation and Rho activation by collagen I, whereas isotype control antibody was without effect (Fig. 6 ). We conclude that collagen I activation of Src and Rho in microvascular ECs requires ligation of ß1 integrins, consistent with earlier findings that collagen I stimulates EC morphogenesis and formation of precapillary cords through this integrin family.



View larger version (60K):
[in this window]
[in a new window]
 
Figure 6. Collagen I activates Src and Rho through ligation of ß1 integrins. A) Neutralizing ß1 integrin antibody (20 µg/mL) blocked collagen I-induced activation of Src in microvascular ECs, as determined by blotting with phospho-specific Src PY418 antibody. B) Neutralizing ß1 integrin antibody (20 µg/mL) also blocked collagen I-induced activation of Rho.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Interstitial collagen I provokes microvascular ECs to align rapidly into solid precapillary cords organized in polygonal arrays. Subsequently, these collagen I-induced cords mature to form capillary-like structures with lumens (9 , 32 , 33) . Collagen I-induced precapillary cords in vitro closely resemble embryonic and adult precapillary cords, which are the precursors to mature blood vessels with lumens in vivo (3 , 4 , 6 , 7 , 34) . As determined here with time-lapse video microscopy, collagen I-induced capillary morphogenesis is a complex dynamic process that begins with EC retraction, motility, and organized realignment. Basement membrane laminin-1 does not provoke microvascular EC assembly into precapillary cords, underscoring distinct differences between the activities of collagen I and laminin-1 in regulating EC morphogenesis.

Because collagen I but not laminin-1 drives microvascular ECs to reorganize into precapillary cords, we hypothesized there were critical matrix-dependent signaling events that control the initiation of morphogenesis. Our experiments confirmed this hypothesis and have defined several key and previously unrecognized events that distinguish collagen I signaling from laminin-1 signaling in microvascular ECs. First, we found that collagen I but not laminin-1 provoked a marked and sustained increase in Src activity, as suggested first by our finding that collagen I induces tyrosine phosphorylation of the Src substrate cortactin and later confirmed by identification of collagen I-induced phosphorylation of Src on tyrosine 418. Moreover, we found that the Src kinase inhibitor PP2 and transduction with dn-Src each inhibited induction of EC morphogenesis by collagen I and that microvascular ECs transduced with wt-Src responded to collagen I by forming precapillary cords more rapidly than ECs transduced with control retrovirus.

Besides sustained activation of Src, we found that collagen I provoked a sustained activation of Rho. In contrast, laminin-1 induced a sustained suppression of Rho activity.

Moreover, we found that the Rho inhibitor C3 transferase suppressed collagen I-induced formation of precapillary cords, linking Rho activation to the mechanism by which collagen I drives EC morphogenesis. Combined inhibition of Src and Rho was most effective at blocking cord formation, indicating that Src and Rho function cooperatively during this process.

Collagen I-induced reorganization of microvascular ECs into precapillary cords requires ligation of ß1 integrins (15) ; as shown here, activation of Src and activation of Rho by collagen I are also dependent on ß1 integrin ligation. Collagen I binds principally the {alpha}1ß1 and {alpha}2ß1 integrins on microvascular ECs (16) ; however, laminin-1 principally binds integrins {alpha}6ß1 and {alpha}6ß4 (our unpublished data). Several reports have suggested possible mechanisms by which ligation of these integrins transmits different signals in microvascular ECs and why laminin-1 provokes a sustained activation of Rac, whereas collagen I induces a brief activation of Rac, followed by sustained suppression of Rac activity to sub-basal levels. Firstly, collagen I decreases cyclic AMP-dependent protein kinase A (PKA) activity in microvascular endothelial cells whereas laminin-1 increases PKA activity (15) . These findings, in combination with findings that Rac activation in carcinoma cells is supported by PKA (35) , raise the intriguing possibility that collagen I suppresses and laminin-1 activates Rac activity through PKA. Secondly, laminin-1 binding to integrin {alpha}6ß4 has been shown to activate phosphoinositide 3-OH kinase in carcinoma cells (36) , which in turn promotes activation of Rac (37) . Finally, our observations that collagen I and laminin-1 exert distinct and, for the most part, opposing actions in regulating Rho GTPases in microvascular ECs are consistent with findings made with epithelial cells, where laminin-1 and collagen I act in opposite ways in regulating subcellular localization of the Rac exchange factor Tiam I (38) .

Regarding the mechanisms by which Rho activation and Src activation initiate capillary morphogenesis, time-lapse phase microscopy described here indicate that collagen I-induced morphogenesis and formation of precapillary cords involve cell retraction and realignment into parallel arrays. In addition, cord formation requires actin polymerization and formation of prominent actin stress fibers (15) , which is consistent with the importance of cell retraction for cord formation because stress fibers mediate cell retraction (31) . Therefore, we defined the involvement of Src and Rho in mediating formation of actin stress fibers and found that both contribute critically. Our findings that Rho is important for stress fiber formation in microvascular ECs are consistent with the well-established functions of this GTPase (20 , 21) . Our finding that Src activity was also required for stress fiber formation was unexpected but not without precedence. For example, in NIH3T3 fibroblasts, Src was found to cooperate with Rho effectors ROCK and mDia to produce prominent actin stress fibers (39) . We found that transduction of microvascular ECs with wt-Src resulted in enhanced stress fiber formation in response to collagen I stimulation, but no differences between control and wt-Src-transduced cells were observed in the absence of collagen I. These observations are consistent with our finding that the morphogenetic response of wt-Src-transduced cells to collagen I was more rapid than that observed with controls. Moreover, they indicate that collagen I stimulation and the associated activation of Src are required for induction of stress fibers.

Time-lapse microscopy also indicated that disruption of cell–cell contacts is a prominent early event in the process whereby collagen I provokes microvascular ECs to form precapillary cords. Disruption of cell–cell contacts is likely critical for both cell motility and cell realignment into parallel arrays. Therefore, we investigated the involvement of Src and Rho in collagen I-induced disruption of cell–cell contacts. Our data indicate that compared with Rho, Src is significantly involved in the mechanism by which collagen I induces the early formation of gaps between microvascular ECs. We found that the Src inhibitor PP2 and transduction with a dn-Src mutant both inhibited the collagen I-induced disruption of the homotypic cell adhesion molecule VE-cadherin from regions of cell–cell contacts. Moreover, transduction with wt-Src accelerated collagen I-induced loss of VE-cadherin from the cell borders and transduction with da-Src mutant prevented the formation of normal VE-cadherin junctions, even in the absence of collagen I. Src activity also has been implicated in the disruption of stable cell–cell adhesion among epidermal keratinocytes (40) ; in colon carcinoma cells, Src activity disrupts normal localization of cadherins to regions of cell–cell contacts (41) . Thus, Src activation appears to be critical for disruption of cell–cell adhesion and cadherin localization in both epithelial and endothelial cells. In contrast, Rac activation has been shown to support rather than disrupt epithelial cell–cell junctions (42 , 43) . Thus, our finding that laminin-1 induces a sustained activation of Rac in microvascular ECs and that it does not disrupt cell–cell contacts is consistent with an established function for Rac in supporting cell–cell junctions.

Src activity has also been implicated as being important for survival of ECs during VEGF-driven angiogenesis and for mediating VEGF induction of microvascular permeability (19) . The involvement of Src in regulating VEGF-mediated increases in microvascular permeability may relate to our findings that Src activity mediates disruption of VE-cadherin. Nonetheless, the biology of microvascular permeability is highly complex and likely involves more than disruption of cell–cell junctions (44) . Consequently, Src may regulate microvascular permeability through multiple mechanisms.

In our view, the most intriguing aspect of findings presented here is that they suggest a model whereby interstitial collagen and basement membrane laminin differentially regulate various stages of angiogenesis. As summarized in Fig. 7 A, interstitial collagen I activation of both Src and Rho promotes formation of prominent actin stress fibers which mediate EC retraction and multicellular reorganization. Collagen I activation of Src disrupts VE-cadherin from cell junctions and promotes disruption of cell–cell contacts, thus facilitating EC morphogenesis. In sharp contrast to collagen I, basement membrane laminin-1 does not provoke EC morphogenesis or induce activation of Src or Rho. Rather, laminin-1 induces persistent activation of the GTPase Rac whereas collagen I suppresses Rac activity after a transient increase. The potential importance of these distinctions in matrix protein signaling for angiogenesis are summarized in Fig. 7B . During the sprouting and proliferative stages of angiogenesis, the laminin-rich basal lamina is degraded, resulting in reduction of EC-laminin interactions. Our data predict that loss of laminin substratum results in reduced Rac activity and therefore a loss of Rac function in supporting integrity of cell–cell junctions during this phase. Moreover, upon degradation of basement membrane, sprouting ECs are exposed to underlying interstitial collagens and begin to invade it, resulting in activation of Src and Rho and initiation of capillary morphogenesis. Subsequently, as the newly formed capillary sprouts mature into new vessels with mature lumens, the intact basement membrane is reestablished. The continuous basement membrane sequesters ECs from interstitial collagens and thereby reestablishes normal activation levels for Rac, Rho, and Src. Thus, as summarized in Fig. 7 , data presented here support a model in which the laminin-rich basement membrane serves not only to maintain the integrity of the mature endothelium but also to sequester and thereby insulate ECs from interstitial collagens. In contrast, degradation of basement membrane exposes ECs to interstitial collagens and activates Src and Rho signaling pathways that drive cytoskeletal reorganization and sprouting morphogenesis.



View larger version (90K):
[in this window]
[in a new window]
 
Figure 7. Summary diagram. Collagen I, but not laminin-1, activates Src and Rho through ß1 integrins resulting in induction of actin stress fibers, disruption of VE-cadherin, and formation of precapillary cords. In contrast, laminin-1 induces Rac activation and does not provoke morphogenesis (A). These marked distinctions in signaling by collagen I and laminin-1 suggest a mechanism by which degradation of basement membrane and exposure of proliferating ECs to collagen I initiates morphogenesis of new capillary sprouts (B). (n/c) = no change.


   ACKNOWLEDGMENTS
 
We thank Mien V. Hoang for help with retrovirus preparation and EC transduction, Mary Whelan for EC isolation and culture, Isaac Rabinovitz for sharing his expertise with time-lapse video microscopy, Joan Brugge for Src retroviral constructs, Martin Schwartz for the Rhotekin-GST construct, and Arthur Mercurio for helpful discussions. This work was supported by the V. Kann Rasmussen Foundation and by a grant from the National Cancer Institute (CA77357 to D.R.S.).

Received for publication September 16, 2003. Accepted for publication November 21, 2003.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Pettersson, A., Nagy, J. A., Brown, L. F., Sundberg, C., Morgan, E., Jungles, S., Carter, R., Krieger, J. E., Manseau, E. J., Harvey, V. S., et al (2000) Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80,99-115[Medline]
  2. Montesano, R., Pepper, M. S. (2001) Capillary morphogenesis in vitro: Cytokine interactions and balanced proteolysis. Voest, E. E. D’Amore, P. A. eds. Tumor Angiogenesis and Microcirculation 24,111-141 Marcel Dekker, Inc. New York, NY.
  3. Drake, C. J., Little, C. D. (1999) VEGF and vascular fusion: implications for normal and pathological vessels. J. Histochem. Cytochem. 47,1351-1355[Abstract/Free Full Text]
  4. Drake, C. J., Brandt, S. J., Trusk, T. C., Little, C. D. (1997) TAL1SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol. 192,17-30[CrossRef][Medline]
  5. Drake, C. J., Fleming, P. A. (2000) Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 95,1671-1679[Abstract/Free Full Text]
  6. Vernon, R. B., Sage, E. H. (1995) Between molecules and morphology: Extracellular matrix and creation of vascular form. Am. J. Pathol. 147,873-883[Abstract]
  7. Aloisi, M., Schiaffino, S. (1971) Growth of elementary blood vessels in diffusion chambers: electron microscopy of capillary morphogenesis. Virchows Arch. B Cell Pathol. 8,328-341[Medline]
  8. Delvos, U., Gajdusek, C., Sage, H., Harker, L. A., Schwartz, S. M. (1982) Interactions of vascular wall cells with collagen gels. Lab. Invest. 46,61-72[Medline]
  9. Montesano, R., Orci, L., Vassalli, P. (1983) In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J. Cell Biol. 97,1648-1652[Abstract/Free Full Text]
  10. Jackson, C. J., Knop, A., Giles, I., Jenkins, K., Schrieber, L. (1994) VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation. Cell Biol. Int. 18,859-867[CrossRef][Medline]
  11. Richard, L., Velasco, P., Detmar, M. (1998) A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells. Exp. Cell Res. 240,1-6[CrossRef][Medline]
  12. Sweeney, S. M., Guy, C. A., Fields, G. B., San Antonio, J. D. (1998) Defining the domains of type I collagen involved in heparin-binding and endothelial tube formation. Proc. Natl. Acad. Sci. USA 95,7275-7280[Abstract/Free Full Text]
  13. Fouser, L., Iruela-Arispe, L., Bornstein, P., Sage, E. H. (1991) Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. J. Biol. Chem. 266,18345-18351[Abstract/Free Full Text]
  14. Iruela-Arispe, M. L., Hasselaar, P., Sage, H. (1991) Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab. Invest. 64,174-186[Medline]
  15. Whelan, M. C., Senger, D. R. (2003) Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J. Biol. Chem. 278,327-334[Abstract/Free Full Text]
  16. Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., Detmar, M. (1997) Angiogenesis promoted by vascular endothelial growth factor: regulation through {alpha}1ß1 and {alpha}2ß1 integrins. Proc. Natl. Acad. Sci. USA 94,13612-13617[Abstract/Free Full Text]
  17. Senger, D. R., Perruzzi, C. A., Streit, M., Koteliansky, V. E., de Fougerolles, A. R., Detmar, M. (2002) The alpha1beta1 and alpha2beta1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160,195-204[Abstract/Free Full Text]
  18. Thomas, S. M., Brugge, J. S. (1997) Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13,513-609[CrossRef][Medline]
  19. Eliceiri, B. P., Schwartzberg, P. L., Hood, J. D., Leng, J., Cheresh, D. A. (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4,915-924[CrossRef][Medline]
  20. Hall, A. (1998) Rho GTPases and the actin cytoskeleton. Science 279,509-514[Abstract/Free Full Text]
  21. Ridley, A. (2001) Rho family proteins: coordinating cell responses. Trends Cell Biol. 11,471-477[CrossRef][Medline]
  22. Mukhopadhyay, D., Tsiokas, L., Zhou, X.-M., Foster, D., Brugge, J. S., Sukhatme, V. P. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375,577-581[CrossRef][Medline]
  23. Le Doux, J. M., Landazuri, N., Yarmush, M., Morgan, J. R. (2001) Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer. Hum. Gene Ther. 12,1611-1621[CrossRef][Medline]
  24. Ren, X. D., Kiosses, W. B., Schwartz, M. A. (1999) Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18,578-585[CrossRef][Medline]
  25. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227,680-685[CrossRef][Medline]
  26. Wu, H., Parsons, J. T. (1993) Cortactin, and 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J. Cell Biol. 120,1417-1426[Abstract/Free Full Text]
  27. Xu, W., Doshi, A., Lei, M., Eck, M. J., Harrison, S. C. (1999) Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3,629-638[CrossRef][Medline]
  28. Obergfell, A., Eto, K., Mocsai, A., Buensuceso, C., Moores, S. L., Brugge, J. S., Lowell, C. A., Shattil, S. J. (2002) Coordinate interactions of Csk, Src, and Syk kinases with alphaIIb/beta 3 initiate integrin signaling to the cytoskeleton. J. Cell Biol. 157,265-275[Abstract/Free Full Text]
  29. Lampugnani, M. G., Corada, M., Caveda, L., Breviario, F., Ayalon, O., Geiger, B., Dejana, E. (1995) The molecular organization of endothelial cell to cell junctions: Differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J. Cell Biol. 129,203-217[Abstract/Free Full Text]
  30. Ridley, A. J., Hall, A. (1992) The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70,389-399[CrossRef][Medline]
  31. Chrzanowska-Wodnicka, M., Burridge, K. (1996) Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133,1403-1415[Abstract/Free Full Text]
  32. Davis, G. E., Camarillo, C. W. (1996) An alpha 2 beta 1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp. Cell Res. 224,39-51[CrossRef][Medline]
  33. Ilan, N., Mahooti, S., Madri, J. A. (1998) Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci. 111,3621-3631
  34. Drake, C. J., Hungerford, J. E., Little, C. D. (1998) Morphogenesis of the first blood vessels. Ann. N. Y. Acad. Sci. 857,155-180[CrossRef][Medline]
  35. O’Connor, K. L., Mercurio, A. M. (2001) Protein kinase A regulates Rac and is required for the growth-factor stimulated migration of carcinoma cells. J. Biol. Chem. 276,47895-47900[Abstract/Free Full Text]
  36. Shaw, L. M., Rabinovitz, I., Wang, H. H., Toker, A., Mercurio, A. M. (1997) Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 91,949-960[CrossRef][Medline]
  37. Schmidt, A., Hall, M. N. (1998) Signaling to the actin cytoskeleton. Annu. Rev. Cell Dev. Biol. 14,305-338[CrossRef][Medline]
  38. Sander, E. E., van Delft, S., ten Klooster, J. P., Reid, T., van der Kammen, R. A., Michiels, F., Collard, J. G. (1998) Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell–cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143,1385-1398[Abstract/Free Full Text]
  39. Tominaga, T., Sahai, E., Chardin, P., McCormick, F., Courtneidge, S. A., Alberts, A. S. (2000) Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol. Cell 5,13-25[CrossRef][Medline]
  40. Owens, D. W., McLean, G. W., Wyke, A. W., Paraskeva, C., Parkinson, E. K., Frame, M. C., Brunton, V. G. (2000) The catalytic activity of Src family kinases is required to disrupt cadherin-dependent cell–cell contacts. Mol. Biol. Cell 11,51-64[Abstract/Free Full Text]
  41. Irby, R. B., Yeatman, T. J. (2002) Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res. 62,2669-2674[Abstract/Free Full Text]
  42. Hordijk, P. L., ten Klooster, J. P., van der Kammen, R. A., Michiels, F., Oomen, L. C. J. M., Collard, J. G. (1997) Inhibition of invasion of epithelial cells by Tiam-Rac signaling. Science 278,1464-1466[Abstract/Free Full Text]
  43. Takaishi, K., Sasaki, T., Kotani, H., Nishioka, H., Takai, Y. (1997) Regulation of cell–cell adhesion by Rac and Rho small G proteins in MDCK cells. J. Cell Biol. 139,1047-1059[Abstract/Free Full Text]
  44. Feng, D., Nagy, J. A., Hipp, J., Dvorak, H. F., Dvorak, A. M. (1996) Vesiculo-vacuolar organelles (VVOs) and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine and serotonin. J. Exp. Med. 183,1981-1986[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
FASEB J.Home page
G. Benton, E. Crooke, and J. George
Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status
FASEB J, November 1, 2009; 23(11): 3884 - 3895.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W. Koh, K. Sachidanandam, A. N. Stratman, A. Sacharidou, A. M. Mayo, E. A. Murphy, D. A. Cheresh, and G. E. Davis
Formation of endothelial lumens requires a coordinated PKC{epsilon}-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation
J. Cell Sci., June 1, 2009; 122(11): 1812 - 1822.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Huveneers and E. H. J. Danen
Adhesion signaling - crosstalk between integrins, Src and Rho
J. Cell Sci., April 15, 2009; 122(8): 1059 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C.A. Stein, S. Wu, A. M. Voskresenskiy, J.-F. Zhou, J. Shin, P. Miller, N. Souleimanian, and L. Benimetskaya
G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis
Clin. Cancer Res., April 15, 2009; 15(8): 2797 - 2807.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Benimetskaya, S. Wu, A. M. Voskresenskiy, C. Echart, J.-F. Zhou, J. Shin, M. Iacobelli, P. Richardson, K. Ayyanar, and C. A. Stein
Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease
Blood, November 15, 2008; 112(10): 4343 - 4352.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. S. Chen
Mechanotransduction - a field pulling together?
J. Cell Sci., October 15, 2008; 121(20): 3285 - 3292.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. A. Singleton, J. G.N. Garcia, and J. Moss
Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis
Mol. Cancer Ther., June 1, 2008; 7(6): 1669 - 1679.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Zhang, N. E. Ramirez, T. E. Yankeelov, Z. Li, L. E. Ford, Y. Qi, A. Pozzi, and M. M. Zutter
{alpha}2{beta}1 integrin expression in the tumor microenvironment enhances tumor angiogenesis in a tumor cell-specific manner
Blood, February 15, 2008; 111(4): 1980 - 1988.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Takeda, A. R. Kazarov, C. E. Butterfield, B. D. Hopkins, L. E. Benjamin, A. Kaipainen, and M. E. Hemler
Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro
Blood, February 15, 2007; 109(4): 1524 - 1532.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. H. Licht, O. T. Pein, L. Florin, B. Hartenstein, H. Reuter, B. Arnold, P. Lichter, P. Angel, and M. Schorpp-Kistner
JunB is required for endothelial cell morphogenesis by regulating core-binding factor {beta}
J. Cell Biol., December 18, 2006; 175(6): 981 - 991.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Z. Ding, A. Lambrechts, M. Parepally, and P. Roy
Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis
J. Cell Sci., October 1, 2006; 119(19): 4127 - 4137.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Qiao, F. Huang, R. P. Naikawadi, K. S. Kim, T. Said, and H. Lum
Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4
Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L91 - L101.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
U. Wollina, W.-D. Schmidt, C. Kronert, C. Nelskamp, A. Scheibe, and D. Fassler
Some Effects of a Topical Collagen-Based Matrix on the Microcirculation and Wound Healing in Patients With Chronic Venous Leg Ulcers: Preliminary Observations
International Journal of Lower Extremity Wounds, December 1, 2005; 4(4): 214 - 224.
[Abstract] [PDF]


Home page
Circ. Res.Home page
G. E. Davis and D. R. Senger
Endothelial Extracellular Matrix: Biosynthesis, Remodeling, and Functions During Vascular Morphogenesis and Neovessel Stabilization
Circ. Res., November 25, 2005; 97(11): 1093 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Lambeng, Y. Wallez, C. Rampon, F. Cand, G. Christe, D. Gulino-Debrac, I. Vilgrain, and P. Huber
Vascular Endothelial-Cadherin Tyrosine Phosphorylation in Angiogenic and Quiescent Adult Tissues
Circ. Res., February 18, 2005; 96(3): 384 - 391.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Rosenkilde, K. A. McLean, P. J. Holst, and T. W. Schwartz
The CXC Chemokine Receptor Encoded by Herpesvirus saimiri, ECRF3, Shows Ligand-regulated Signaling through Gi, Gq, and G12/13 Proteins but Constitutive Signaling Only through Gi and G12/13 Proteins
J. Biol. Chem., July 30, 2004; 279(31): 32524 - 32533.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIU, Y.
Right arrow Articles by SENGER, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIU, Y.
Right arrow Articles by SENGER, D. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS